文献速递血液透析通路

血栓性动静脉通路的挽救:专科血管通路中心的结局

Salvage of Thrombosed Arteriovenous Access: Outcomes from a Dedicated Vascular Access Center.
PubMed 文献 · Ann Vasc Surg · 2026-07-14

该回顾性队列研究纳入2017至2021年间8个透析中心转诊至专科血管通路中心的152例血栓性AVF或AVG患者,评估开放与腔内联合策略的结局。临床与技术成功率分别为91.2%和89.2%,3个月一期通畅率78.3%,自体AVF显著优于AVG或复合AVF。

要点

  • 开放取栓是主要方式(90.8%),经皮取栓仅3.3%且40%转开放。
  • 流出道狭窄见于76.3%,高压球囊扩张是最常用辅助手段(85.4%)。
  • 3个月一期通畅率自体AVF显著优于AVG或复合AVF(P<0.01)。

核心结论

  • 具备整合手术-腔内能力的专科血管通路中心可高效挽救血栓性AV通路,结局超过已发表基准。

研究设计与样本

  • 回顾性队列研究,纳入2017至2021年8个透析中心转诊的152例血栓性AVF或AVG患者。
  • 患者平均年龄71.5±12.9岁,65.1%为男性。

主要发现

  • 开放取栓占90.8%,经皮取栓占3.3%,经皮取栓转开放率为40%。
  • 流出道狭窄占76.3%,高压球囊扩张为最常见辅助手段(85.4%)。
  • 临床成功率91.2%,技术成功率89.2%。
  • 总体3个月一期通畅率78.3%,自体AVF显著优于AVG或复合AVF(P<0.01)。
  • 6个月一期通畅率67.1%、一期辅助通畅率74.3%;12个月分别为50.0%和58.6%。

临床怎么用

  • 对血栓性AV通路应优先转诊至具备手术与腔内整合能力的专科血管通路中心。
  • 取栓后需评估并处理流出道狭窄,高压球囊扩张是常用辅助手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vascular access thrombosis is the leading cause of arteriovenous (AV) access loss in hemodialysis patients, yet the optimal treatment strategy remains debated. This study evaluates outcomes of approach of AV access thrombosis in a specialized vascular access center. METHODS: Retrospective cohort study including all patients with thrombosed AV fistula (AVF) or AV graft (AVG) referred from 8 dialysis units between 2017 and 2021 to a dedicated, exclusively focused vascular access center with integrated surgical-endovascular capabilities. Technical and clinical success, stenosis pattern, and access-specific outcomes were evaluated. Primary, assisted primary, and secondary patency at 3, 6, and 12 months were analyzed using Kaplan-Meier methods. RESULTS: A total of 152 patients were included with a mean age was 71.5 ± 12.9 years; 65.1% were male. Thrombosis incidence increased from 5.5% pre-coronavirus disease (COVID) to 9.6% during the pandemic (P = 0.04). Open thrombectomy was performed in 90.8% of cases; percutaneous thrombectomy in 3.3%, with a 40% cross-over rate to open technique. Outflow stenosis was identified in 76.3%; high-pressure balloon angioplasty was the most common adjunct (85.4%). Clinical and technical success rates were 91.2% and 89.2%, respectively. Global 3-month primary patency was 78.3%, significantly superior for autologous AVF versus AVG or compound AVF (P < 0.01). At 6 months, primary patency was 67.1% and primary assisted patency was 74.3% and at 12 months primary patency was 50.0% and primary assisted patency was 58.6%. The median follow-up duration was 720 days (23.6 months). CONCLUSION: A dedicated vascular access center with integrated hybrid capabilities and experienced vascular surgeons providing daily availability achieved high outcomes in thrombosed AV access salvage, exceeding published benchmarks. This model emphasizes the critical importance of specialization, accessibility, and integrated surgical-endovascular expertise in managing dialysis access emergencies to ensure that AV access thrombosis is not an end point but a manageable complication.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Machado M, Almeida P, Teles P, et al. Salvage of Thrombosed Arteriovenous Access: Outcomes from a Dedicated Vascular Access Center. Ann Vasc Surg. 2026. PMID: 42448036. doi:10.1016/j.avsg.2026.06.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。